Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease

Journal of Endocrinology

Volumn 150, Issue SUPPL., 1996, Pages

  Khaw, K T ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE; PRASTERONE SULFATE;

CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY RISK; HEART PROTECTION; HORMONAL THERAPY; HORMONE ACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANIMALS; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; MALE; MIDDLE AGED; RABBITS; RISK FACTORS;

EID: 0029855972     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Barrett-Connor E & Khaw K-T 1987 Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women. New England Journal of Medicine 317 711.
2. Barrett-Connor E & Edelstein SL 1994 A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bemardo Study. Journal of the American Geriatric Society 42 420-423.
3. Barrett-Connor E, Khaw K-T & Yen SSC 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease New England Journal of Medicine 315 1519-1524.
4. Cleary MP & Zisk JF 1986 Anti obesity effect of 2 different levels of dehydroepiandrosterone in lean and obese middle-aged female Zucker rats. International Journal of Obesity 10 193-204.
5. Coleman DL, Leiter EH & Schwizer RW 1982 Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31 830-833.
6. Gordon GB, Bush DE & Weisman HF 1988 Reduction of atherosclerosis by administration of dehydroepiandrosterone. Journal of Clinical Investigation 82 712-720.
7. Haffner SM, Newcomb PA, Marcus PM, Klein BEK & Klein R 1995 Relation of sex hormones and dehydroepiandrosterone sulfate to cardiovascular risk factors in postmenopausal women. American Journal of Epidemiology 142 925-934.
8. Hautanen A, Manttari M, Manninen V, Tenkanen L, Huttunen JK, Fnck MH & Adlercreutz H 1994 Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study Atherosclerosis 105 191-200.
9. Hernington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich PO & Pearson TA 1990 Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfite in patients undergoing diagnostic coronary angiography. Journal of American College of Cardiology 16 862-870.
10. Kask E 1959 17 Ketosteroids and arteriosclerosis Angiology 10 358-368.
11. Khaw KT, Tazuke S & Barrett-Connor E 1988 Cigarette smoking and levels of idrenal indrogens in postmenopausal women. New England Journal of Medicine 318 1705-1709.
12. LaCroix AZ, Yano K & Reed DM 1992 Dehydroepiandrosterone sulfate, incidence of myocardial infarction and extent of atherosclerosis in men. Circulation 86 1529-1535.
13. Marmorston J, Lewis JJ, Bernstein JL, Sobel H, Kuzma O, Alexander R, Magidson O & Moore FJ 1957 Excretion of urinary steroids by men and women with myocardial infarction. Geriatrics 12 297-300.
14. Marmorston J, Griffith GC, Geller PJ, Fishman EL, Welsch F & Weiner JM 1975 Urinary steroids in the measurement of aging and of atherosclerosis. Journal of the American Geriatric Society 23 481-492.
15. Mitchell LE, Sprecher DL, Borecki JB, Rice T, Laskarezewski PM & Rao DC 1994 Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation 89 89-93
16. Morales AJ, Nolan JJ, Nelson JC & Yen SSC 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. Journal of Clinical Endocrinology and Metabolism 78 1360-1367.
17. Mortola J & Yen SSC 1990 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 71 696-704.
18. Nestler JE, Barlascini CO, Clore JN & Blackard WG 1988 Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men Journal of Clinical Endocrinology and Metabolism 66 57-61.
19. Newcomer LM, Manson JE, Barbieri RL, Hennekens CH & Stampfer MJ 1994 Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians a prospective study. American Journal of Epidemiology 140 870-875.
20. Slowinska-Srzednicka J, Zgliczynski S, Ciswicka-Sznajderman M, Srzednicki M, Soszynski P, Biernacka M, Woroszylska M, Ruzyllo W & Sadowski Z 1989 Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis 79 197-203.
21. Usiskin KS, Butterworth S, Clore JN, Arad Y, Ginsberg HN, Blackard WG & Nestler JE 1990 Lack of effect of DHEA in obese men. International Journal of Obesity 14 457-463.
22. Yen TT, Allan JA, Pearson DV, Acton JM & Greenberg MM 1977 Prevention of obesity in Avy/a Mice by dehydroepiandrosterone. Lipids 12 409-413.
23. Zumoff B, Troxler RC & O'Connor J 1982 Abnormal hormone levels in men with coronary artery disease. Arteriosclerosis 2 58-67.